SeaStar Medical (NASDAQ:ICU – Get Rating) and Lyra Therapeutics (NASDAQ:LYRA – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares SeaStar Medical and Lyra Therapeutics’ […]
Shares of Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Rating) traded down 2.5% on Monday . The company traded as low as $1.93 and last traded at $1.98. 35,678 shares changed hands during mid-day trading, a decline of 0% from the average session volume of 35,844 shares. The stock had previously closed at $2.03. Analyst Ratings […]
Lyra Therapeutics (LYRA) Restarts Phase 3 ENLIGHTEN II Clinical Trial of LYR-210 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Lyra Therapeutics Announces Restart of Pivotal Phase 3 ENLIGHTEN II Clinical Trial of LYR-210 in Chronic Rhinosinusitis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Goeasy: Well-Placed to Adapt to Potential Rate Change by Accelerating Strategy of Continously Reducing Weighted Average Interest Rate Charged to Borrowers; To Keep Expanding Products, Distribution Channels, Leveraging Risk-Based Pricing to Cut Borrowin. | 06:14am